These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 23929619

  • 21. Targeting cancer stem cells through L1CAM suppresses glioma growth.
    Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE, Hjelmeland AB, Rich JN.
    Cancer Res; 2008 Aug 01; 68(15):6043-8. PubMed ID: 18676824
    [Abstract] [Full Text] [Related]

  • 22. Leptin enhances the invasive ability of glioma stem-like cells depending on leptin receptor expression.
    Han G, Zhao W, Wang L, Yue Z, Zhao R, Li Y, Zhou X, Hu X, Liu J.
    Brain Res; 2014 Jan 16; 1543():1-8. PubMed ID: 24161825
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effects of prenylated isoflavones osajin and pomiferin in premedication on heart ischemia-reperfusion.
    Florian T, Necas J, Bartosikova L, Klusakova J, Suchy V, Naggara EB, Janostikova E, Bartosik T.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Jul 16; 150(1):93-100. PubMed ID: 16936909
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Potential of Horse Apple Isoflavones in Targeting Inflammation and Tau Protein Fibrillization.
    Abourashed EA, Abraha A, Khan SI, McCants T, Awan S.
    Nat Prod Commun; 2015 Sep 16; 10(9):1577-80. PubMed ID: 26594763
    [Abstract] [Full Text] [Related]

  • 27. Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3.
    Wan Y, Fei XF, Wang ZM, Jiang DY, Chen HC, Yang J, Shi L, Huang Q.
    Chin J Cancer; 2012 Apr 16; 31(4):207-14. PubMed ID: 22360855
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells.
    Barrantes-Freer A, Renovanz M, Eich M, Braukmann A, Sprang B, Spirin P, Pardo LA, Giese A, Kim EL.
    PLoS One; 2015 Apr 16; 10(6):e0130519. PubMed ID: 26086074
    [Abstract] [Full Text] [Related]

  • 31. Enhanced invasion in vitro and the distribution patterns in vivo of CD133+ glioma stem cells.
    Yu SP, Yang XJ, Zhang B, Ming HL, Chen C, Ren BC, Liu ZF, Liu B.
    Chin Med J (Engl); 2011 Sep 16; 124(17):2599-604. PubMed ID: 22040410
    [Abstract] [Full Text] [Related]

  • 32. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
    Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, Tsai TH, Chou SH, Chien CS, Ku HH, Lo JF.
    Clin Cancer Res; 2008 Jul 01; 14(13):4085-95. PubMed ID: 18593985
    [Abstract] [Full Text] [Related]

  • 33. Pomiferin.
    Marek J, Veselá D, Lisková M, Zemlicka M.
    Acta Crystallogr C; 2003 Mar 01; 59(Pt 3):o127-8. PubMed ID: 12711784
    [Abstract] [Full Text] [Related]

  • 34. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.
    Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, Nikkhah G, Dimeco F, Piccirillo S, Vescovi AL, Eberhart CG.
    Stem Cells; 2010 Jan 01; 28(1):5-16. PubMed ID: 19904829
    [Abstract] [Full Text] [Related]

  • 35. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y, Pan G, Chen L, Ma S, Zeng T, Man Chan TH, Li L, Lian Q, Chow R, Cai X, Li Y, Li Y, Liu M, Li Y, Zhu Y, Wong N, Yuan YF, Pei D, Guan XY.
    Gastroenterology; 2015 Oct 01; 149(4):1068-81.e5. PubMed ID: 26099525
    [Abstract] [Full Text] [Related]

  • 36. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
    Di K, Linskey ME, Bota DA.
    Oncogene; 2013 Oct 17; 32(42):5038-47. PubMed ID: 23178488
    [Abstract] [Full Text] [Related]

  • 37. Importance of PKCδ signaling in fractionated-radiation-induced expansion of glioma-initiating cells and resistance to cancer treatment.
    Kim MJ, Kim RK, Yoon CH, An S, Hwang SG, Suh Y, Park MJ, Chung HY, Kim IG, Lee SJ.
    J Cell Sci; 2011 Sep 15; 124(Pt 18):3084-94. PubMed ID: 21878493
    [Abstract] [Full Text] [Related]

  • 38. Brain cancer stem cells display preferential sensitivity to Akt inhibition.
    Eyler CE, Foo WC, LaFiura KM, McLendon RE, Hjelmeland AB, Rich JN.
    Stem Cells; 2008 Dec 15; 26(12):3027-36. PubMed ID: 18802038
    [Abstract] [Full Text] [Related]

  • 39. Eckol suppresses maintenance of stemness and malignancies in glioma stem-like cells.
    Hyun KH, Yoon CH, Kim RK, Lim EJ, An S, Park MJ, Hyun JW, Suh Y, Kim MJ, Lee SJ.
    Toxicol Appl Pharmacol; 2011 Jul 01; 254(1):32-40. PubMed ID: 21514314
    [Abstract] [Full Text] [Related]

  • 40. Overexpression of CD133 promotes drug resistance in C6 glioma cells.
    Angelastro JM, Lamé MW.
    Mol Cancer Res; 2010 Aug 01; 8(8):1105-15. PubMed ID: 20663862
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.